ANNEX I, Commission Regulation (EU) No 286/2011 of 10 March 2011 amending, for the purposes of it…

In forcesince 19 Apr 2011

A. Part 1 of Annex I to Regulation (EC) No 1272/2008 is amended as follows:

(1)

in section 1.1.2.2.2, the Note under Table 1.1 is replaced by the following:

Generic cut-off values are in weight percentages except for gaseous mixtures for those hazard classes where the generic cut-off values may be best described in volume percentages.’;

(2)

in section 1.1.3.1, the beginning of the first sentence is replaced by ‘If a tested mixture’;

(3)

sections 1.1.3.2, 1.1.3.3 and 1.1.3.4 are replaced by the following:

The hazard category of a tested production batch of a mixture can be assumed to be substantially equivalent to that of another untested production batch of the same commercial product, when produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the untested batch has changed. If the latter occurs, a new evaluation is necessary.

In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a tested mixture is classified in the highest hazard category or sub-category, and the concentration of the components of the tested mixture that are in that category or sub-category is increased, the resulting untested mixture shall be classified in that category or sub-category without additional testing.

In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures (A, B and C) with identical components, where mixtures A and B have been tested and are in the same hazard category, and where untested mixture C has the same hazardous components as mixture A and B but has concentrations of those hazardous components intermediate to the concentrations in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.’;

(4)

in section 1.1.3.5, the last sentence is replaced by the following:

‘If mixture (i) or (ii) is already classified based on test data, then the other mixture shall be assigned the same hazard category.’;

(5)

sections 1.2, 1.2.1, 1.2.1.1, 1.2.1.2 and 1.2.1.3 are replaced by the following:

1.2.1.1.

Hazard pictograms shall be in the shape of a square set at a point.

1.2.1.2.

Hazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.

1.2.1.3.

Each hazard pictogram shall cover at least one fifteenth of the minimum surface area of the label dedicated to the information required by Article 17. The minimum area of each hazard pictogram shall not be less than 1 cm2.

1.2.1.4.

The dimensions of the label and of each pictogram shall be as follows:

Capacity of the package | Dimensions of the label (in millimetres) for the information required by Article 17 | Dimensions of each pictogram (in millimetres)

Not exceeding 3 litres: | If possible, at least 52 × 74 |

Not smaller than 10 × 10

If possible, at least 16 × 16

Greater than 3 litres but not exceeding 50 litres: | At least 74 × 105 | At least 23 × 23

Greater than 50 litres but not exceeding 500 litres: | At least 105 × 148 | At least 32 × 32

Greater than 500 litres: | At least 148 × 210 | At least 46 × 46’

(6)

the introductory sentence in section 1.5.2.1.3 is replaced by the following:

‘The pictogram, the signal word, the hazard statement, and the precautionary statement linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:’;

(7)

in section 1.5.2.2, point (b) is replaced by the following:

‘(b) The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b), 1.5.2.1.2 (b) or 1.5.2.1.3 (b); and’.

B. Part 2 of Annex I to Regulation (EC) No 1272/2008 is amended as follows:

(1)

section 2.1.4.1 is amended as follows:

(a)

the footnote under Figure 2.1.1 is replaced by the following:

‘(*) See UN Recommendations on the Transport of Dangerous Goods, Model Regulations, 16th rev. ed, sub-section 2.1.2.’;

(b)

Figure 2.1.3 is replaced by the following:

’

(c)

Figure 2.1.4, is replaced by the following:

’

(2)

in section 2.1.4.2, the Note is replaced by the following:

Neither a series 1 type (a) propagation of detonation test nor a series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g. For organic substances and mixtures of organic substances with a decomposition energy of 800 J/g or more, tests 1 (a) and 2 (a) need not be performed if the outcome of the ballistic mortar Mk.IIId test (F.1), or the ballistic mortar test (F.2) or the BAM Trauzl test (F.3) with initiation by a standard No 8 detonator (see Appendix 1 to the UN RTDG, Manual of Tests and Criteria) is “no”. In this case, the results of test 1 (a) and 2 (a) are deemed to be “-”.’;

(3)

in section 2.2.2.1, the Note under Table 2.2.1 is replaced by the following:

Aerosols shall not be classified as flammable gases; see section 2.3.’;

(4)

in section 2.3.2.1, the Note is replaced by the following notes:

Flammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents.

Flammable aerosols do not fall additionally within the scope of sections 2.2 (flammable gases), 2.6 (flammable liquids) or 2.7 (flammable solids).’;

(5)

in section 2.3.2.2, the following Note is inserted at the end of the paragraph:

Aerosols not submitted to the flammability classification procedures in this section shall be classified as flammable aerosols, Category 1.’;

(6)

in section 2.4.2.1, the Note under Table 2.4.1 is replaced by the following:

“Gases which cause or contribute to the combustion of other material more than air does” mean pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended.’;

(7)

in section 2.5.3, the following Note is inserted under Table 2.5.2:

Pictogram GHS04 is not required for gases under pressure where pictogram GHS02 or pictogram GHS06 appears.’;

(8)

in section 2.6.2.1 the following Note is inserted under Table 2.6.1:

Aerosols shall not be classified as flammable liquids; see section 2.3.’;

(9)

section 2.6.4.2 is amended as follows:

(a)

the first paragraph is replaced by the following:

‘In the case of mixtures [To date, the calculation method has been validated for mixtures containing up to 6 volatile components. These components may be flammable liquids like hydrocarbons, ethers, alcohols, esters (except acrylates), and water. It is however not yet validated for mixtures containing halogenated sulphurous, and/or phosphoric compounds as well as reactive acrylates.] containing known flammable liquids in defined concentrations, although they may contain non-volatile components e.g. polymers, additives, the flash point need not be determined experimentally if the calculated flash point of the mixture, using the method given in 2.6.4.3, is at least 5 °C [If the calculated flash point is less than 5 °C greater than the relevant classification criterion, the calculation method may not be used and the flash point should be determined experimentally.’;] greater than the relevant classification criterion (23 °C and 60 °C, respectively) and provided that:

(b)

in point (b), the words ‘of the mixture’ shall be added;

(10)

in section 2.6.4.4, Table 2.6.3, the complete row ‘British Standard Institute, BS 2000 Part 170 as amended (identical to EN ISO 13736)’ is deleted;

(11)

section 2.6.4.5 is replaced by the following:

‘2.6.4.5

Liquids with a flash point of more than 35 °C and not more than 60 °C need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN RTDG, Manual of Tests and Criteria.’;

(12)

the following new section 2.6.4.6 is inserted:

‘2.6.4.6.

Possible test methods for determining the initial boiling point of flammable liquids are listed in Table 2.6.4.

[OJ L 142, 31.5.2008, p. 1.’]

European standards: |

EN ISO 3405 as amended

Petroleum products — Determination of distillation characteristics at atmospheric pressure

EN ISO 3924 as amended

Petroleum products — Determination of boiling range distribution — Gas chromatography method

EN ISO 4626 as amended

Volatile organic liquids — Determination of boiling range of organic solvents used as raw materials

Regulation (EC) No 440/2008 | Method A.2 as described in Part A of the Annex to Regulation (EC) No 440/2008

(13)

in section 2.7.2.3, the Note under Table 2.7.1 is replaced by the following:

The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.

Aerosols shall not be classified as flammable solids; see section 2.3.’;

(14)

in section 2.8.4.2, Figure 2.8.1, points 7.4, 8.4 and 9.4, the word ‘No’ is replaced by ‘None’;

(15)

section 2.11.1.2 is replaced by the following:

‘2.11.1.2.

Self-heating of a substance or a mixture is a process where the gradual reaction of that substance or mixture with oxygen (in the air) generates heat. If the rate of heat production exceeds the rate of heat loss, then the temperature of the substance or mixture will rise which, after an induction time, may lead to self-ignition and combustion.’;

(16)

in section 2.15.4.2, Figure 2.15.1, points 7.4, 8.4 and 9.4, the word ‘No’ is replaced by ‘None’.

C. Part 3 of Annex I to Regulation (EC) No 1272/2008 is amended as follows:

(1)

section 3.1.2.1 is replaced by the following:

‘3.1.2.1.

Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). Explanatory notes are shown following Table 3.1.1.

[Gas concentrations are expressed in parts per million per volume (ppmV).]

Exposure route | Category 1 | Category 2 | Category 3 | Category 4

Oral (mg/kg bodyweight) | ATE ≤ 5 | 5 < ATE ≤ 50 | 50 < ATE ≤ 300 | 300 < ATE ≤ 2000

See: |

Note (a)

Note (b)

Dermal (mg/kg bodyweight) | ATE ≤ 50 | 50 < ATE ≤ 200 | 200 < ATE ≤ 1000 | 1000 < ATE ≤ 2000

See: |

Note (a)

Note (b)

Gases (ppmV) | ATE ≤ 100 | 100 < ATE ≤ 500 | 500 < ATE ≤ 2500 | 2500 < ATE ≤ 20000

see: |

Note (a)

Note (b)

Note (c)

Vapours (mg/l) | ATE ≤ 0,5 | 0,5 < ATE ≤ 2,0 | 2,0 < ATE ≤ 10,0 | 10,0 < ATE ≤ 20,0

see: |

Note (a)

Note (b)

Note (c)

Note (d)

Dusts and mists (mg/l) | ATE ≤ 0,05 | 0,05 < ATE ≤ 0,5 | 0,5 < ATE ≤ 1,0 | 1,0 < ATE ≤ 5,0

see: |

Note (a)

Note (b)

Note (c)

Notes to Table 3.1.1:

(a)

The acute toxicity estimate (ATE) for the classification of a substance is derived using the LD50/LC50 where available.

(b)

The acute toxicity estimate (ATE) for the classification of a substance in a mixture is derived using:

the LD50/LC50 where available,

the appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or

the appropriate conversion value from Table 3.1.2 that relates to a classification category.

(c)

Generic concentration limits for inhalation toxicity in the table are based on 4-hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1-hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.

(d)

For some substances the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2500 ppmV), Category 4 (20000 ppmV).

The terms “dust”, “mist” and “vapour” are defined as follows:

dust: solid particles of a substance or mixture suspended in a gas (usually air),

mist: liquid droplets of a substance or mixture suspended in a gas (usually air),

vapour: the gaseous form of a substance or mixture released from its liquid or solid state.

Dust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm.’;

(2)

section 3.1.3.2 is replaced by the following:

‘3.1.3.2.

For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all components and there is no relevant evidence to suggest acute toxicity by multiple routes. When there is relevant evidence of toxicity by multiple routes of exposure, classification is to be conducted for all appropriate routes of exposure. All available information shall be considered. The pictogram and signal word used shall reflect the most severe hazard category and all relevant hazard statements shall be used.’;

(3)

in section 3.1.3.3, points (c) and (d) are added:

‘(c) If the converted acute toxicity point estimates for all components of a mixture are within the same category, then the mixture should be classified in that category.

(d)

When only range data (or acute toxicity hazard category information) are available for components in a mixture, they may be converted to point estimates in accordance with Table 3.1.2 when calculating the classification of the new mixture using the formulas in sections 3.1.3.6.1 and 3.1.3.6.2.3.’;

(4)

section 3.1.3.5.2 is replaced by the following:

‘3.1.3.5.2.

If a tested mixture is diluted with a diluent that has an equivalent or lower toxicity classification than the least toxic original components, and which is not expected to affect the toxicity of other components, then the new diluted mixture may be classified as equivalent to the original tested mixture. Alternatively, the formula explained in section 3.1.3.6.1 can be applied.’;

(5)

section 3.1.3.6.1, is amended as follows:

(a)

point (c) is replaced by the following:

‘(c) ignore components if the data available are from a limit dose test (at the upper threshold for Category 4 for the appropriate route of exposure as provided in Table 3.1.1) and do not show acute toxicity.’;

(b)

the first sentence beneath point (c) is replaced by the following:

‘Components that fall within the scope of this section are considered to be components with a known acute toxicity estimate (ATE). See note (b) to Table 3.1.1 and section 3.1.3.3 for appropriate application of available data to the equation below, and section 3.1.3.6.2.3.’;

(6)

in section 3.1.3.6.2.1, point (a), the footnote is replaced by the following:

‘(1) When mixtures contain components that do not have acute toxicity data for each route of exposure, acute toxicity estimates may be extrapolated from the available data and applied to the appropriate routes (see section 3.1.3.2). However, specific legislation may require testing for a specific route. In those cases, classification shall be performed for that route based upon the legal requirements.’;

(7)

section 3.1.3.6.2.2 is replaced by the following:

‘3.1.3.6.2.2.

In the event that a component without any useable information for classification is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known components only, with the additional statement on the label and in the SDS that: “× percent of the mixture consists of component(s) of unknown toxicity”.’;

(8)

in section 3.1.3.6.2.3, the title of Table 3.1.2 is replaced by the following:

(9)

the following sentence is added to section 3.1.4.1:

‘Without prejudice to Article 27, combined hazard statements may be used in accordance with Annex III.’;

(10)

in Tables 3.1.3, 3.2.5, 3.3.5, 3.4.4 and 3.8.4, the pictogram with the exclamation mark is replaced by the following pictogram:

‘’;

(11)

in section 3.4.1.5 the words ‘at section 3.4.4.’ are replaced by ‘in Annex II, section 2.8.’;

(12)

in section 3.4.1.6 the word ‘and’ is inserted after ‘Respiratory Sensitisation’;

(13)

sections from 3.4.2 to 3.4.2.2.4.1 are replaced by the following:

3.4.2.1.1.1.

Respiratory sensitisers shall be classified in Category 1 where data are not sufficient for sub-categorisation.

3.4.2.1.1.2.

Where data are sufficient a refined evaluation according to 3.4.2.1.1.3 shall allow the allocation of respiratory sensitisers into sub-category 1A, strong sensitisers, or sub-category 1B for other respiratory sensitisers.

3.4.2.1.1.3.

Effects seen in either humans or animals will normally justify classification in a weight of evidence approach for respiratory sensitisers. Substances may be allocated to one of the two sub-categories 1A or 1B using a weight of evidence approach in accordance with the criteria given in Table 3.4.1 and on the basis of reliable and good quality evidence from human cases or epidemiological studies and/or observations from appropriate studies in experimental animals.

3.4.2.1.1.4.

Substances shall be classified as respiratory sensitisers in accordance with the criteria in Table 3.4.1:

[At present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment.]

Category | Criteria

Category 1 |

Substances shall be classified as respiratory sensitisers (Category 1) where data are not sufficient for sub-categorisation in accordance with the following criteria:

(a)

if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity; and/or

(b)

if there are positive results from an appropriate animal test.

Sub-category 1A: | Substances showing a high frequency of occurrence in humans; or a probability of occurrence of a high sensitisation rate in humans based on animal or other tests. Severity of reaction may also be considered.

Sub-category 1B: | Substances showing a low to moderate frequency of occurrence in humans; or a probability of occurrence of a low to moderate sensitisation rate in humans based on animal or other tests. Severity of reaction may also be considered.

3.4.2.1.2.1.

Evidence that a substance can lead to specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.

3.4.2.1.2.2.

When considering the human evidence, it is necessary for a decision on classification to take into account, in addition to the evidence from the cases:

(a)

the size of the population exposed;

(b)

the extent of exposure.

The use of human data is discussed in sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.

3.4.2.1.2.3.

The evidence referred to above could be:

(a)

clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:

(i)

in vivo immunological test (e.g. skin prick test);

(ii)

in vitro immunological test (e.g. serological analysis);

(iii)

studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;

(iv)

a chemical structure related to substances known to cause respiratory hypersensitivity;

(b)

data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.

3.4.2.1.2.4.

Clinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.

3.4.2.1.2.5.

The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.

3.4.2.1.3.1.

Data from appropriate animal studies [At present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment.] which may be indicative of the potential of a substance to cause sensitisation by inhalation in humans [The mechanisms by which substances induce symptoms of asthma are not yet fully known. For preventative measures, these substances are considered respiratory sensitisers. However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyper reactivity, they should not be considered as respiratory sensitisers.’;] may include:

(a)

measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;

(b)

specific pulmonary responses in guinea pigs.

3.4.2.2.1.1.

Skin sensitisers shall be classified in Category 1 where data are not sufficient for sub-categorisation.

3.4.2.2.1.2.

Where data are sufficient a refined evaluation according to section 3.4.2.2.1.3 allows the allocation of skin sensitisers into sub-category 1A, strong sensitisers, or sub-category 1B for other skin sensitisers.

3.4.2.2.1.3.

This article is long: the rest is at the official publication.